GlaxoSmithKline's central nervous system treatment drug Rapidone approved for new indications for bipolar disorder
Saisin Pharma completes $100 million round A financing to focus on the development of new drugs for the central nervous system
Saisin Pharma completes $100 million round A financing to focus on the development of new drugs for the central nervous system
LVYE pharmaceutical precisely distributes the field of central nervous system, and another new drug applies for NDA in the United States
Contact Us
Trade Alert - Delivering the latest product trends and industry news straight to your inbox.
(We`ll never share your email address with a third-party.)
鲁ICP备16009155号-1 | Copyright@Qingdao ECHEMI Technology Co., Ltd.
Welcome to ECHEMI